| Record ID | marc_columbia/Columbia-extract-20221130-034.mrc:2369645:3836 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-034.mrc:2369645:3836?format=raw |
LEADER: 03836cam a2200601Ia 4500
001 16610649
005 20220627125823.0
006 m o d
007 cr |n|---|||||
008 120611s2012 flua ob 000 0 eng d
010 $a 2012013741
035 $a(OCoLC)ocn795120447
035 $a(NNC)16610649
040 $aEBLCP$beng$epn$cEBLCP$dOCLCQ$dN$T$dYDXCP$dWAU$dTXA$dOCLCQ$dCOO$dOCLCQ$dB24X7$dIDEBK$dDEBSZ$dOCLCQ$dCRCPR$dOCLCQ$dE7B$dDEBBG$dUMI$dOCLCQ$dEBLCP$dOCLCQ$dMERUC$dUAB$dVT2$dOCLCF$dOCLCQ$dCEF$dOCLCA$dOCLCQ$dUKMGB$dWYU$dG3B$dYDX$dLEAUB$dUKAHL$dOCLCQ$dEYM$dOCLCO
015 $aGBB7A5350$2bnb
016 7 $a018380798$2Uk
019 $a802048611$a880575142$a1008956679$a1048179173$a1065805806$a1086453185$a1181907454$a1192348886$a1240514635
020 $a9781439899793$q(electronic bk.)
020 $a1439899797$q(electronic bk.)
020 $a9781466568044
020 $a1466568046
020 $a9781466568037$q(e-book)
020 $a1466568038
020 $z9781439899700$q(hbk. ;$qalk. paper)
020 $z1439899703$q(hbk. ;$qalk. paper)
035 $a(OCoLC)795120447$z(OCoLC)802048611$z(OCoLC)880575142$z(OCoLC)1008956679$z(OCoLC)1048179173$z(OCoLC)1065805806$z(OCoLC)1086453185$z(OCoLC)1181907454$z(OCoLC)1192348886$z(OCoLC)1240514635
037 $aCL0500000433$bSafari Books Online
050 4 $aHD9665.5$b.H358 2012eb
072 7 $aBUS$x070000$2bisacsh
082 04 $a338.4/79151$223
049 $aZCUA
100 1 $aHandfield, Robert B.
245 10 $aBiopharmaceutical supply chains :$bdistribution, regulatory, systems and structural changes ahead /$cRobert Handfield.
260 $aBoca Raton :$bCRC Press,$c©2012.
300 $a1 online resource (ix, 262 pages) :$billustrations
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
504 $aIncludes bibliographical references.
505 0 $a1. Biopharmaceutical Distribution: Early Structural Developments and the Changes Ahead -- 2. Key Forces and Myths of Distribution in the BPS Supply Chain -- 3. Regulatory Trends -- 4. The Last Mile: Changes in the Hospital Environment That Impact the Life Sciences -- 5. The Blurring of Boundaries in Biopharmaceutical Supply Chains: The Case of Oncology Medicine -- 6. The Changing Landscape of the Life Sciences Supply Chain: Recommendations for Players in the Industry.
520 $a"The global pharmaceutical industry has been subjected to many challenges in the last decade, including more blockbuster drugs reaching the end of their patent life, increased regulation, pricing pressure, channel pressure, counterfeiting, and challenges in clinical trials management. This book covers the major themes and changes in the biopharmaceutical supply chain. It provides an overview of the key challenges and discusses how leading biopharma companies are dealing with these challenges. Bringing together leading researchers and industry executives, it is a must-read for those who want to learn more about achieving success in this industry"--Provided by publisher.
588 0 $aPrint version record.
650 0 $aPharmaceutical industry$xMaterials management.
650 0 $aBusiness logistics.
650 6 $aIndustrie pharmaceutique$xGestion de l'approvisionnement.
650 6 $aLogistique (Organisation)
650 7 $aBUSINESS & ECONOMICS$xIndustries$xGeneral.$2bisacsh
650 7 $aBusiness logistics.$2fast$0(OCoLC)fst00842759
655 0 $aElectronic books.
655 4 $aElectronic books.
776 08 $iPrint version:$aHandfield, Robert B.$tBiopharmaceutical supply chains.$dBoca Raton, FL : CRC Press, ©2012$z9781439899700$w(DLC) 2012013741$w(OCoLC)769420419
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio16610649$zTaylor & Francis eBooks
852 8 $blweb$hEBOOKS